Home  >  Products  >  COL8A2 (collagen, type VIII, alpha 2) Blocking Peptide (the C terminal of COL8A2)(100ug)
COL8A2 (collagen, type VIII, alpha 2) Blocking Peptide (the C terminal of COL8A2)(100ug)

COL8A2 (collagen, type VIII, alpha 2) Blocking Peptide (the C terminal of COL8A2)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-COL8A2 Antibody (ARP60022_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60022
Size: 100ug
Weight: 67kDa
Gene: 1296
Format: Lyophilized powder
Target: COL8A2 is the alpha 2 chain of type VIII collagen. The protein is a major component of the basement membrane of the corneal endothelium and forms homo- or heterotrimers with alpha 1 (VIII) type collagens. Defects in this COL8A2 gene are associated with Fuchs endothelial corneal dystrophy and posterior polymorphous corneal dystrophy type 2
Alternative names: FECD; FECD1; FLJ00201; MGC116970; MGC116972; PPCD; PPCD2